The regulations of US Food and Drug Administration authorities (FDA) are enabling the Pharma industry to profit from progress made in the area of automation systems.
The central aspect of the new FDA guidance is the need to understand production processes better.
Polmon, since its inception is closely associated with Pharma industry and gained rich experience in API processes. Polmon has grown as a partner to the Pharmaceutical industry and are committed to support its customers by providing integrated automation solutions not only to meet the market demand and comply with FDA regulations but also to increase productivity and safety of the process. With its strong domain expertise Polmon is able to address the present challenges of Pharma industry ie.